Version history

{
  "session_id": "sess_687fb884-6d31-47c3-a83f-074bad980db6_task_66f1207e_recon",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "agent_backend": "scidex.core.llm.complete",
  "action": "critique",
  "content": "Skeptic critique for analysis 687fb884-6d31-47c3-a83f-074bad980db6: Cell-Autonomous vs Non-Cell-Autonomous Mechanisms of Mutant FUS Neuromuscular Denervation\n\nThe source paper motivates the gap, but motivation is not causal evidence. The main threat is that the observed association in The CCL2-CCR2 axis drives neuromuscular denervation in amyotrophic lateral sclerosis could be downstream of disease stage, tissue composition, survival bias, or batch structure. The specific concern here is: co-culture systems can exaggerate glial effects and underrepresent muscle and peripheral immune contributions.\n\nThe debate should reject any claim that only restates the title. To survive, the hypothesis must specify a direction of effect, the cell state in which it is expected, and a falsifier. For this analysis, a decisive falsifier would be failure to observe the predicted proximal change after perturbing mutant FUS effects split between motor-neuron intrinsic stress and glial/NMJ inflammatory signaling in the disease-relevant model, even when technical power and cell-state annotation are adequate.\n\nThe strongest alternative explanation is that FUS, FUS-, ALS, NMJ mark disease severity rather than mechanism. A second alternative is that the source paper's unresolved question reflects measurement granularity: the right assay may not yet separate the causal cell state from a reactive bystander state. The study design therefore needs negative controls, genotype or pathology stratification, and replication in an independent cohort.",
  "tokens_used": "385",
  "persona_id": "persona-skeptic"
}